Bank of New York Mellon Corp Has $440,000 Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Bank of New York Mellon Corp lifted its stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 13.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 193,109 shares of the company’s stock after purchasing an additional 22,280 shares during the quarter. Bank of New York Mellon Corp owned 0.23% of Stereotaxis worth $440,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. SG Americas Securities LLC increased its holdings in shares of Stereotaxis by 39.2% during the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock valued at $60,000 after acquiring an additional 7,417 shares during the last quarter. Jane Street Group LLC raised its position in shares of Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after purchasing an additional 6,313 shares during the period. Wealth Effects LLC lifted its stake in shares of Stereotaxis by 11.7% in the fourth quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock worth $196,000 after buying an additional 9,000 shares during the last quarter. Barclays PLC boosted its holdings in shares of Stereotaxis by 449.9% during the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after buying an additional 83,412 shares during the period. Finally, Traynor Capital Management Inc. acquired a new position in Stereotaxis in the 4th quarter valued at $366,000. 45.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Stereotaxis

In other news, Director Paul J. Isaac bought 38,000 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was acquired at an average price of $1.81 per share, for a total transaction of $68,780.00. Following the transaction, the director now directly owns 87,299 shares of the company’s stock, valued at $158,011.19. This trade represents a 77.08 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 18.52% of the stock is owned by insiders.

Stereotaxis Stock Down 4.3 %

STXS opened at $1.80 on Friday. Stereotaxis, Inc. has a 1-year low of $1.66 and a 1-year high of $3.29. The company has a 50 day simple moving average of $2.14. The company has a market capitalization of $152.51 million, a PE ratio of -6.43 and a beta of 1.54.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.